The U.S. State Department has approved a potential sale of munitions to Israel valued at an estimated $151.8 million, according to an official notification. Secretary of State Marco Rubio determined that an emergency exists requiring the immediate approval of the sale, which allows for the exemption of the usual legislative review process under the Arms Export Control Act. The approval comes amid the war between Israel and Iran, in which the United States is also participating, following a military escalation in the region in recent weeks. Washington justified the sale by stating that it will contribute to its foreign policy and national security by strengthening Israel's defense capabilities against regional threats and supporting a key U.S. strategic partner in the Middle East. The State Department also indicated that a portion of the BLU-110A/B munitions will be transferred from existing U.S. inventories, and the prime contractor for the operation will be Repkon USA, based in Texas. Meanwhile, President Donald Trump stated this Friday that some of the main contractors for his country's armed forces promised him they would quadruple the production of high-end weaponry. This commitment arrives as doubts persist about the depth of Washington's most advanced arsenal in the war against Iran. "They agreed to quadruple the production of 'exquisite class' weaponry, as we want to reach maximum production levels as quickly as possible," Trump wrote in a message on his social media Truth after what he called "an excellent meeting" with representatives of defense sector companies.
